Literature DB >> 1350762

Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid-responsive element.

D Szapary1, H Oshima, S S Simons.   

Abstract

Previous studies have documented that the amount of agonist activity expressed by the antiglucocorticoid dexamethasone 21-mesylate (Dex-Mes) for tyrosine aminotransferase (TAT) induction in two rat hepatoma cell lines (Fu5-5 and HTC) is greater in Fu5-5 cells and could be varied in each cell line with changes in cell density. We have proposed that both phenomena are mediated by the binding of a trans-acting factor, the concentration or activity of which is lower in HTC cells. We have now used DNase-I hypersensitivity studies to identify a possible binding site for this factor at around -3.6 kilobases (kb) of the TAT gene. Fu5-5 and HTC cells were then stably transfected with hybrid constructs either with (3.9TATCAT) or without (2.9TATCAT) this region of the TAT gene fused up-stream of a chloramphenicol acetyltransferase (CAT) reporter gene. High levels of Dex-Mes agonist activity for the induction of CAT activity in Fu5-5 cells were seen only with the 3.9TATCAT construct, indicating that the 0.97-kb region unique to this construct controlled the high levels of Dex-Mes agonist activity. Furthermore, variations in Fu5-5 cell density caused major quantitative changes in the amount of Dex-Mes agonist activity only in cells containing the 3.9TATCAT construct, consistent with the same 0.97-kb sequences also controlling the variations in Dex-Mes agonist activity. Additional studies at high and low cell densities revealed that the modulation of Dex-Mes agonist activity for both the endogenous TAT gene and the transfected TAT/CAT gene was not due to changes in the start site of gene transcription. These studies both support our previous hypothesis that modulation of Dex-Mes agonist activity results from changes in a trans-acting factor and localize a necessary cis-acting element to sequences between -3.9 and -2.9 kb of the TAT gene. These studies, thus, define a potentially new element for glucocorticoid regulation of TAT gene transcription.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350762     DOI: 10.1210/endo.130.6.1350762

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Differential modulation of glucocorticoid and progesterone receptor transactivation.

Authors:  Daniele Szapary; Liang-Nian Song; Yuangzheng He; S Stoney Simons
Journal:  Mol Cell Endocrinol       Date:  2007-12-08       Impact factor: 4.102

2.  The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes.

Authors:  Timothy E Reddy; Jason Gertz; Gregory E Crawford; Michael J Garabedian; Richard M Myers
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

3.  Genomic organization of human GMEB-1 and rat GMEB-2: structural conservation of two multifunctional proteins.

Authors:  H Zeng; S Kaul; S S Simons
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.